Improvement of fasting plasma glucose level after ingesting moderate amount of dietary fiber in Japanese men with mild hyperglycemia and visceral fat obesity

Journal of Dietary Supplements

Volumn 10, Issue 2, 2013, Pages 129-141

  Kobayakawa, Akira ^a   Suzuki, Tomoo ^a   Ikami, Takao ^a   Saito, Morio ^a   Yabe, Daisuke ^b   Seino, Yutaka ^b  

^a Miki Seisakusyo Co   (Japan)

^b KANSAI ELECTRIC POWER CO   (Japan)

Author keywords

Body mass index; Body weight; Dietary fiber; Fasting plasma glucose; Subcutaneous fat; Visceral fat

Indexed keywords

ANTIDIABETIC AGENT; ANTIOBESITY AGENT;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BLOOD; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY FIBER; DOUBLE BLIND PROCEDURE; ECHOGRAPHY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; JAPAN; MALE; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION; YOUNG ADULT;

ADIPOSITY; ADULT; AGED; ANTI-OBESITY AGENTS; BODY MASS INDEX; DIETARY FIBER; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; JAPAN; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; PREDIABETIC STATE; TOMOGRAPHY, X-RAY COMPUTED; WEIGHT LOSS; YOUNG ADULT;

EID: 84878588832     PISSN: 19390211     EISSN: 1939022X     Source Type: Journal    
DOI: 10.3109/19390211.2013.790335     Document Type: Article

References (45)

1. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Adams-Huet B, Grundy SM. Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM. Diabetes. 1996;45:1684-1893.
2. Anderson JW, Randles KM, Kendall CW, Jenkins DJS. Carbohydrate and fber recommendations for individuals with diabetes: a quantitative assessment and meta-analysis of the evidence. J Am Coll Nutr. 2004;23:5-17.
3. Barnard ND, Jaster B, Cohen J, Seidl K, Jenkins DJA, Green AA, Turner-McGrievy G, Talpers S, Gloede L. A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial inindividuals with type 2 diabetes. Diabetes Care.2006;29:1777-1783.
4. Burton-Freeman B. Dietary fber and energy regulation. J Nutr. 2000;130:272S-275S.
5. Sadiq Butt M, Tahir-Nadeem M, Khan MKI, Shabir R, Butt MS. Oat: unique among the cereals. Eur J Clin Nutr. 2008;47:68-79.
6. Chandalia M, Garg A, Luthohann D, Bergmann KV, Grundy SM, Brinkley LJ. Benefcial effects of high dietary fber intake in patients with type 2 diabetes mellitus. N Engl J Med. 2000;342:1392-1398.
7. Coudray C, Bellanger J, Castiglia-Delavaud C, Remesy C, Vermorel M, Rayssignuier Y. Effect of soluble or partially soluble dietary fbers supplementation on absorption and balance of calcium, magnesium, iron and zinc in healthy young men. Eur J Nutr. 1997;51:375-380.
8. Davidson MH, Maki KC. Effects of dietary inulin on serum lipids. J. Nutr. 1999;129:1474S-1477S.
9. Dikeman CL, Murphy MR, Fahey GC, Jr. Dietary fbers affect viscosity of solutions and simulated human gastric and small intestinal digesta. J Nutr. 2006;136:913-919.
10. Gu YH, Yamashita T, Suzuki I, Rj Juneja L, Yokawa T. Effects of enzyme hydrolyzed guar gum on the elevation of blood glucose levels after meal (in Japanese). Med Biol. 2003;147:19-24.
11. Häkeläinen H, Anttila H, Sihovonen J, Hietanen RM, Tahvonen R, Salminen E, Mikola M, Sontag-Strohm T. The effect of β-glucan on the glycemic and insulin index. Eur J Clin Nutr. 2007;61:779-785.
12. Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010;11:11-8.
13. Jenkins AL, Jenkins DJA, Zdravkovic U, Würsch P, Vuksan V. Depression of the glycemic index by high levels of β-glucan fber in two functional foods tested in type 2 diabetes. Eur. J Clin Nutr. 2002;56:622-628.
14. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006;116:1784-1792.
15. Kim MS, Kim JY, Choi WH, Lee SS. Effects of seaweed supplementation on blood glucose concentration, lipid profle, and antioxidant enzyme activities in patients with type 2 diabetes mellitus. Nutr Res Prac. 2008;2:62-67.
16. Kok NN, Morgan LM, Williams CM, Roberfroid MB, Thissen JP, Delzenne M. Insulin, glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide and insulin-like growth factor I as putative mediators of the hypolipidemic effect of oligofructose in rats. J Nutr. 1998;128:1099-1103.
17. Kosaka K, Kuzuya T, Yoshinaga H, Hagura R. A prospective study of health check examinees for the development of non-insulin-dependent diabetes mellitus: relationship of the incidence of diabetes with the initial insulinogenic index and degree of obesity. Diabetic Med. 1996;13:S120-S126.
18. Kurowski TG, Lin Y, Luo Z, Tsichlis PN, Buse MG, Heydrick SJ, Ruderman NB. Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle. Diabetes. 1999;48:658-663.
19. Li R, Zhng P, Barker LE, Chowdhury FM, Zhang X. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care. 2010;33:1872-1894.
20. Massimino SP, McBurney MI, Field CJ, Thomson ABR, Keelan M, Hayek MG, Sunvold GD. Fermentable dietary fber increases GLP-1 secretion and improves glucose home-ostasis despite increased intestinal glucose transport capacity in healthy dogs. J Nutr. 1998;128:1786-1793.
21. Matsuzawa Y. The role of fat topology in the risk of disease. Int J Obes. 2008;32:S83-S92.
22. Meyer C, Szoke E, Pimenta W, Woerle HJ, Mitrakou A, Woerle HJ, Gerich J, Haeften TV. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care. 2006;29:1909-1914.
23. Ministry of Health, Labour, and Welfare, Japan. Dietary reference intakes for Japanese (2010), Carbohydrate. pp. 111-112. Tokyo: Dai-Ichi Shuppan, 2009.
24. Nakamura T, Yoshizumi T. Measurement of visceral fat by CT scan (in Japanese). Nippon Rinsho. 2006;64:476-480.
25. Nawano M, Ueta K, Oku A, Arakawa K, Saito A, Funaki M, Anai M, Kikuchi M, Oka Y, Asano T. Hyperglycemia impairs the insulin signaling step between PI 3-kinase and Akt/PKB activations in ZDF rat liver. Biochem Biophys Res Commun. 1999;266:252-256.
26. Noda M, Kato M, Takahashi Y, Matsushita Y, Mizoue T, Inoue M, Tsugane S, Kadowaki T. Fasting plasma glucose and 5-year incidence of diabetes in the JPHC diabetes study-suggestion for the threshold for impaired fasting glucose among Japanese. Endocrine J. 2010;57:629-637.
27. Ohmura T, Ueda K, Kiyohara Y, Kato I, Iwamoto H, Nakayama K, Nomiyama K, Ohmori S, Yoshitake T, Shinkawa A, Hasuo Y, Fujishima M. The association of the insulin resistance syndrome with impaired glucose tolerance and NIDDM in the Japanese general population: the Hisayama study. Diabetologia. 1994;37:897-904.
28. Pereira MA, Jacobs DR, Pins JJ, Raatz SK, Gross MD, Slavin JL, Seaquist ER. Effect of whole grains on insulin sensitivity in overweight hyperinsulinemic adults. Am J Clin Nutr. 2002;75:848-855.
29. Sakamoto A, Ishizawa Y, Toda E, Nagai R, Koike K, Yamakado M, Ishizuka N. Impact ofchanges in obesity parameters on glucose metabolism and insulin resistance over a one-year period. J Atheroscler Thrombosis. 2010;17:1246-1255.
30. Seino Y, Fukushima M, Yabe D. GIP and GLP-1, the two incretin hormones: Similarities and differences. J Diabetes Invest. 2010;1:8-23.
31. Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, Hanafusa T, Haneda M, Ueki K. Report of the committee on the classifcation and diagnostic criteria of diabetes mellitus. J Diabetes Invest. 2010;1:212-228.
32. Sekikawa A, Tominaga M, Takahashi K, Eguchi H, Igarashi M, Ohnuma H. Prevalence of diabetes and impaired glucose tolerance inFunagata area, Japan. Diabetes Care. 1993;16:570-574.
33. Slavin JL. Dietary fber and body weight. Nutrition. 2005;21:411-418.
34. Sood N, Baker WL, Coleman CI. Effects of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis. Am J Nutr. 2008;88:1167-1175.
35. Takahashi T, Yokawa T, Ishihara N, Okubo T, Chu DC, Nishigaki E, Kawada Y, Kato M, Raj Juneja L. Hydrolyzed guar gum decreases postprandial blood glucose and glucose absorption in the rat small intestine. Nutr Res. 2009;29:419-425.
36. Taniguchi A, Fukushima M, Sakai M, Kataoka K, Nagata I, Doi K, Arakawa H, Nagasaka S, Tokuyama K, Nakai Y. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients. Metabolism. 2000;49:1001-1005.
37. Taniguchi A, Nakai Y, Sakai M, Yoshii S, Hamanaka D, Hatae Y, Kawata M, Yamanouchi K, Okumura T, Doi K, Tokuyama K, Nagasaka S, Fukushima M. Relationship of regional adiposity to insulin resistance and serum triglyceride levels in nonobese Japanese type 2 diabetic patients. Metabolism. 2002;51:544-548.
38. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Saiminen V, Uusitupa M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350.
39. Turner-McGrievy GM, Garnard ND, Cohen J, Jenkins DJA, Gloede L, Green AA. Changes in nutrient intake and dietary quality among participants wit type 2 diabetes following a low-fat vegan diet or a conventional diabetes diet for 22 weeks. J Am Diet Assoc. 2008;108:1636-1645.
40. Weaver GA, Tangel C, Krause JA, Alpern HD, Jenkins PL, Parftt MM, Stragand JJ. Dietary guar gum alters colonic microbial fermentation in azoxymethane-treated rats. J Nutr. 1996;126:1979-1991.
41. Weickert MO, Möhlig M, Schöf C, Arafat AM, Otto B, Viehoff H, Koebnick C, Kohl A, Spranger J, Pfeiffer AF. Cereal fber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care. 2006;29:775-780.
42. Weickert MO, Pfeiffer FH. Metabolic effects of dietary fber consumption and prevention of diabetes. J Nutr. 2008;138:439-442.
43. Wild S, Sicree R, Roglic G, King H, Green A. Global prevalence of diabetes: estimate for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.
44. Wolfram T, Ismail-Beigi F. Effcacy of high fber diets in the management of type 2 diabetes mellitus. Endocr Prac. 2011;17:132-142.
45. Zhou J, Martin RJ, Tulley RT, Raggio AM, McCutcheon KL, Shen L, Danna SC, Tripathy S, Hegsted M, Keenan MJ. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am J Physiol Endocrinol Metab. 2008;295:E1160-1166.